DTHF News & Events
Variables Affecting PrEP Adherence in Black MSM
23 October 2017In South Africa, there are a predicted 800 thousand to 1.8 million men who have sex with men (MSM). This is a key population to target for HIV prevention since MSM in 38 low- and m...
Read more
IAVI Fellows Research HIV Risk Perception and Hepatitis B
20 October 2017The International AIDS Vaccine Initiative (IAVI) has a fantastic fellowship program, and two of their fellows have been researching at the Desmond Tutu HIV Foundation. Separately, they have researched why peo...
Read more
How Do You Do, Desmond Tutu HIV Foundation?
20 October 2017The Desmond Tutu HIV Foundation (DTHF) has an active presence in our local communities in Cape Town. Vuyiseka Mpongoshe has completed a pilot study examining how our presence is felt in these communities to see if we are leaving a lasting impression. There is no doubt that the Desmond Tutu HIV Foundation has a lot of value in community settings: we send ...
Read more
Building an HIV-free generation in Masiphumelele
17 October 2017The Desmond Tutu HIV Foundation has several studies for young women who want to prevent HIV by taking an oral pill, PrEP. PrEP stands for pre-exposure prophylaxis (‘prophylaxis’ means to prevent disease). Oral PrEP is a pill (Truvada) that is taken once a day to prevent HIV infection. The details of the 3P study are below, including who can join the study and how to ap...
Read more
Recognising Gender Violence is Key to Ending HIV
17 October 2017Everyone has heard of the different ways that HIV can spread: unprotected sex, sharing needles and childbirth to name a few. But, there is another dangerous perpetrator of HIV that is less obvious: violence against women. Violence against women is a social structure that helps spread HIV infection. It works by affecting women’s ability to negotiate when they have sex, what HIV prevention tool...
Read more
DTHF Partners with Coral Healthcare
16 October 2017Coral Healthcare (India & Australia) have undertaken to provide their top quality condoms to the DTHF as their commitment to being, “proactive doers in the worlds in which we function”. We eagerly look forward to the first consignment that should arrive at the end of October. An Agreement has been signed between the DTHF and Coral Healthcare whereby Coral Healthcare condoms will reach i...
Read more
Women test discrete HIV prevention options
4 October 2017A daily pill, a monthly vaginal ring or an injection every two months: These were the prevention options available to young women on the uChoose study to help them prevent HIV infection. Brady Hooley, from the Desmond Tutu HIV Foundation, presented the findings of this study. There are many new prevention tools becoming avai...
Read more
HIV Cure Symposium: Experts Speak on the Elusive Cure for HIV
2 October 2017Key figures leading the fight against HIV discussed the status of the elusive HIV cure. Chaired by Prof Linda-Gail Bekker, Chief Operations Officer at the Desmond Tutu HIV Foundation, the speakers discussed why we need an HIV cure, is a cure possible and what that cure might look like. [caption id="attachment_5888" align="aligncenter" width="300"]...
Read more
The Only Man Cured of HIV, Timothy Ray Brown, Speaks
2 October 2017Only one man has ever been cured of HIV. Timothy Ray Brown has been living ten years since an extremely dangerous procedure that removed all the HIV in his body. Frequently referred to as the 'Berlin Patient' based on the city the procedure was performed in, Brown came to the "Is an HIV Cure possible?" symposium at the Desmond Tutu HIV Foundation in Cape Town to add to the discussion on the curren...
Read more
Dolutegravir Access: Achieved!
22 September 2017At the UN General Assembly meeting Michel Sidibe, Executive Director of UNAIDS, announced that an exciting new pricing agreement has been made to accelerate the availability of the first affordable, generic, single-pill HIV treatment, which will contain Dolutegravir. ...
Read more
Pill Fatigue in PrEP is the Biggest Challenge in Fighting HIV in Adolescents
11 September 2017The Plus Pills study, led by Professor Bekker, is a part of a three-part study examining PrEP use in different groups. PrEP, which stands for PreExposure Prophylaxis, is an HIV prevention drug that can be taken by HIV-negative people to protect them from infec...
Read more
Busting Myths about PrEP
11 September 2017PrEP is an everyday pill that an HIV negative person can take to prevent getting HIV. Consistent use is essential for protection. Since PrEP is still a relatively new advancement in HIV prevention technology, there are still a lot of concerns and misconceptions around it. Fortunately, there has been a flurry of research in the drug and Prof Linda-Gail Bekker, COO of the Desmond Tutu HIV Foun...
Read more